RegenBrief
Research Brief
Recent papers in stem cell, exosome, and functional longevity research — summarized in plain language. Filter by topic or indication using the tags below.
Regenerative Medicine in 2026: What the Latest Papers Show
From cell therapy to secretome, EVs, and delivery platforms
2026.05.12
RegenBrief
MSC
secretome
EV
Can Stem Cell Therapy Improve Frailty?
From CRATUS and Laromestrocel to Zhu 2024 and Nguyen 2026 — what the MSC frailty trials actually show
2026.05.09
RegenBrief
MSC
frailty
anti-aging
MSC-Derived Exosome Nanoformulations Emerge as Next-Generation Drug Delivery Platform for Targeted Cancer Therapy
Review in International Journal of Pharmaceutics maps biological rationale for delivering chemotherapy, RNA therapeutics, and immunomodulators to tumors / Current evidence is primarily preclinical — standardization, scale-up, and long-term safety remain key hurdles
2026.05.03
RegenBrief
MSC
exosome
nanoformulation
Why Immunogenicity Is the Core Issue in Stem Cell Therapy
Umbilical cord-derived MSCs offer structural advantages in immunogenicity — but the optimal cell source depends on the disease and treatment strategy
2026.04.30
RegenBrief
MSC
immunogenicity
umbilical cord
Exosome Skin Treatments: Growing Promise, Standards Yet to Catch Up
Microneedling combination therapy shows early signals in alopecia, skin aging, and pigmentation — experts say verifying source, manufacturing, quality control, and regulatory standards comes first
2026.04.30
RegenBrief
exosome
dermatology
microneedling
Exosomes Emerge as a New Frontier in Depression Research
A Molecular Psychiatry review proposes exosomes as key mediators linking neuroinflammation, synaptic plasticity, and the gut-brain axis in depression
2026.04.29
RegenBrief
exosome
depression
neuroinflammation